ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

584 hedge funds and large institutions have $30B invested in Alnylam Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 234 increasing their positions, 179 reducing their positions, and 61 closing their positions.

Holders
584
Holders Change
+25
Holders Change %
+4.47%
% of All Funds
7.78%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
95
Increased
234
Reduced
179
Closed
61
Calls
$195M
Puts
$166M
Net Calls
+$29M
Net Calls Change
-$10.2M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.64B
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$1.03B
3
Qube Research & Technologies (QRT)
3
Qube Research & Technologies (QRT)
United Kingdom
$114M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$89.1M
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$191M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$334M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$3.17B
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$951M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$988M
5
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$101M
Name Holding Trade Value Shares
Change 		Shares
Change %
Invesco
26
Invesco
Georgia
$131M -$32.3M -137,378 -20%
Deutsche Bank
27
Deutsche Bank
Germany
$131M +$4.07M +17,308 +3%
Charles Schwab
28
Charles Schwab
California
$121M +$6.26M +26,614 +5%
Amundi
29
Amundi
France
$119M -$23.3M -97,019 -16%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$119M +$3.71M +15,755 +3%
Loomis, Sayles & Company
31
Loomis, Sayles & Company
Massachusetts
$118M -$5.24M -22,258 -4%
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$114M +$78.4M +333,098 +219%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$113M +$1.12M +4,764 +1%
Nuveen Asset Management
34
Nuveen Asset Management
Illinois
$106M +$1.83M +7,789 +2%
Pictet Asset Management
35
Pictet Asset Management
Switzerland
$101M -$55.1M -234,110 -35%
Bank of America
36
Bank of America
North Carolina
$98.5M -$31.1M -132,220 -24%
O
37
OrbiMed
New York
$97.8M +$38.9M +165,300 +66%
Franklin Resources
38
Franklin Resources
California
$97.5M +$7.33M +31,166 +8%
Marshall Wace
39
Marshall Wace
United Kingdom
$89.1M +$74.2M +315,182 +497%
GGHC
40
Gilder Gagnon Howe & Co
New York
$86M -$4.36M -18,530 -5%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$85.4M +$7.24M +30,780 +9%
Swiss National Bank
42
Swiss National Bank
Switzerland
$85.3M -$3.01M -12,800 -3%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$78.5M +$7.59M +32,272 +11%
Millennium Management
44
Millennium Management
New York
$78.5M +$19.4M +82,479 +33%
First Trust Advisors
45
First Trust Advisors
Illinois
$77.1M +$9.93M +42,211 +15%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$73M -$23.7M -100,879 -25%
PCH
47
Polar Capital Holdings
United Kingdom
$72.9M – – –
Goldman Sachs
48
Goldman Sachs
New York
$72.1M -$11.7M -49,645 -14%
UBS Group
49
UBS Group
Switzerland
$68.2M +$31.6M +134,295 +86%
Sumitomo Mitsui Trust Group
50
Sumitomo Mitsui Trust Group
Japan
$67.5M +$1.99M +8,462 +3%
1
2
3 4 5